Treatment concepts of acute promyelocytic leukemia : Acute leukemiasLENGFELDER, Eva; SAUSSELE, Susanne; WEISSER, Andreas et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 2, pp 261-274, issn 1040-8428, 14 p.Article

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVFABARIUS, Alice; LEITNER, Armin; JUNG-MUNKWITZ, Susanne et al.Blood. 2011, Vol 118, Num 26, pp 6760-6768, issn 0006-4971, 9 p.Article

The European LeukemiaNet: achievements and perspectivesHEHLMANN, Rüdiger; GRIMWADE, David; BÜCHNER, Thomas et al.Haematologica (Roma). 2011, Vol 96, Num 1, pp 156-162, issn 0390-6078, 7 p.Article

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreHASFORD, Joerg; BACCARANI, Michele; SIMONSSON, Bengt et al.Blood. 2011, Vol 118, Num 3, pp 686-692, issn 0006-4971, 7 p.Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNetGUILHOT, Joëlle; BACCARANI, Michele; ROUSSELOT, Philippe et al.Blood. 2012, Vol 119, Num 25, pp 5963-5971, issn 0006-4971, 9 p.Article

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid LeukemiaHEHLMANN, Rüdiger; LAUSEKER, Michael; HÄNEL, Mathias et al.Journal of clinical oncology. 2011, Vol 29, Num 12, pp 1634-1642, issn 0732-183X, 9 p.Article

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IVSAUSSELE, Susanne; LAUSEKER, Michael; SCHLIMOK, Günter et al.Blood. 2010, Vol 115, Num 10, pp 1880-1885, issn 0006-4971, 6 p.Article